WNT PROTEIN SIGNALLING INHIBITORS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20150374696A1
SERIAL NO

14728105

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention generally relates to protein signalling. In particular, compounds that inhibit the Wnt protein signalling pathway are disclosed. Such compounds may be used in the treatment of Wnt protein signalling-related diseases and conditions such as cancer, degenerative diseases, type II diabetes and osteopetrosis.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM210 WEST 7TH STREET AUSTIN TEXAS 78701 78701

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
CHEN, Baozhi Addison, US 5 15
CHEN, Chuo Dallas, US 30 109
DODGE, Michael E Irving, US 3 11
LUM, Lawrence Dallas, US 15 62
ROTH, Michael G Dallas, US 3 11
TANG, Wei Beijing, CN 187 2813

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation